Age group | Vaccinated cases | Unvaccinated cases | Under the age of vaccination | Unknown | Total | |
---|---|---|---|---|---|---|
< 1 years | 7 (0.9%) | 68 (9.0%) | 155 (20.4%) | 6 (0.8%) | 235 (31.1%) | |
1 to 4 years | 68 (9.0%) | 24 (3.2%) | 0 (0%) | 8 (1.1%) | 100 (13.2%) | |
5 to 9 years | 54 (7.1%) | 16 (2.1%) | 0 (0%) | 18 (2.4%) | 88 (11.6%) | |
10 to 14 years | 40 (5.3%) | 3 (0.4%) | 0 (0%) | 14 (1.8%) | 57 (7.5%) | |
15 to 19 years | 14 (1.8%) | 7 (0.9%) | 0 (0%) | 21 (2.8%) | 42 (5.5%) | |
20 to 24 years | 6 (0.8%) | 3 (0.4%) | 0 (0%) | 12 (1.6%) | 21 (2.8%) | |
25 to 29 years | 2 (0.3%) | 9 (1.2%) | 0 (0%) | 7 (0.9%) | 18 (2.4%) | |
30 to 39 years | 3 (0.4%) | 7 (0.9%) | 0 (0%) | 15 (2.0%) | 25 (3.3%) | |
40 to 59 years | 2 (0.3%) | 6 (0.8%) | 0 (0%) | 17 (2.2%) | 25 (3.3%) | |
60 ≤ years | 0 (0.0%) | 1 (0.1%) | 0 (0%) | 2 (0.3%) | 3 (0.4%) | |
Unknown | 2015–2016 | 0 (0%) | 0 (0.0%) | 0 (0%) | 2 (0.3%) | 2 (0.3%) |
2014a | 16 (2.1%) | 51 (6.7%) | 33 (4.3%) | 42 (5.5%) | 142 (18.7%) | |
TOTAL | 212 (27.9%) | 195 (25.7%) | 188 (24.8%) | 164 (21.6%) | 759 (100%) |